State of the art POWHEG generators for top mass measurements at the LHC

We study the theoretical uncertainties in the determination of the top-quark mass using next-to-leading-order (NLO) generators, that describe the top-quark decay at different levels of accuracy, interfaced to parton showers (PS). Specifically we consider one generator that implements NLO corrections only in the production dynamics, one that also takes them into account in the top-quark decay in the narrow width approximation (NWA) and one that implements them exactly, including finite-width and interference effects. We aim at assessing the errors in top-mass determinations of purely theoretical origin. We do so by measuring relative peak position shifts of $Wb$-jet mass distributions. Besides the theoretical errors due to the use of less accurate NLO+PS generators, we also explore uncertainties related to shower and modelling of non-perturbative effects by comparing the results obtained by interfacing our generators to both Pythia and Herwig shower Monte Carlos (SMCs).Comment: Proceedings of the XXVI International Workshop on Deep-Inelastic Scattering and Related Subjects (DIS2018), 16-20 April 2018, Kobe, Japa

All-orders behaviour and renormalons in top-mass observables

We study a simplified model of top production and decay, consisting in a virtual vector boson $W^*$ decaying into a massive-massless $t$-$\bar{b}$ quark-antiquark pair. The top has a finite width and further decays into a stable vector boson $W$ and a $b$ quark. We then consider the emission or the virtual exchange of one gluon, with all possible light-quark loop insertions. These are the dominant diagrams in the limit of an infinite number of light flavours. We devise a procedure to compute this process fully, by analytic and numerical methods, and for any infrared-safe final-state observables. We examine the results at arbitrary orders in perturbation theory, and assess the factorial growth associated with renormalons. We look for renormalon effects leading to corrections of order $\Lambda_{\rm QCD}$, that we dub `linear' renormalons, in the inclusive cross section (with and without selection cuts), in the mass of the reconstructed-top system, and in the average energy of the final-state $W$ boson, considering both the pole and the $\overline{\rm MS}$ scheme for the top mass. We find that the total cross section without cuts, if expressed in terms of the $\overline{\rm MS}$ mass, does not exhibit linear renormalons, but, as soon as selection cuts are introduced, jets-related linear renormalons arise in any mass scheme. In addition, we show that the reconstructed mass is affected by linear renormalons in any scheme and that the average energy of the $W$ boson (that we consider as a simplified example of leptonic observable), in any mass scheme, has a renormalon in the narrow-width limit, that is however screened at large orders for finite top widths, provided the top mass is in the $\overline{\rm MS}$ scheme.Comment: 40 pages, 17 figure

Next-to-leading-logarithmic PanScales showers for Deep Inelastic Scattering and Vector Boson Fusion

We introduce the first family of parton showers that achieve next-to-leading logarithmic (NLL) accuracy for processes involving a $t$-channel exchange of a colour-singlet, and embed them in the PanScales framework. These showers are applicable to processes such as deep inelastic scattering (DIS), vector boson fusion (VBF), and vector boson scattering (VBS). We extensively test and verify the NLL accuracy of the new showers at both fixed order and all orders across a wide range of observables. We also introduce a generalisation of the Cambridge-Aachen jet algorithm and formulate new DIS observables that exhibit a simple resummation structure. The NLL showers are compared to a standard transverse-momentum ordered dipole shower, serving as a proxy for the current state-of-the-art leading-logarithmic showers available in public codes. Depending on the observable, we find discrepancies at NLL of the order of $15\%$. We also present some exploratory phenomenological results for Higgs production in VBF. This work enables, for the first time, to resum simultaneously global and non-global observables for the VBF process at NLL accuracy.Comment: 34 pages + 10 pages of Appendices, 13 figure

Next-to-leading-logarithmic PanScales showers for deep inelastic scattering and vector boson fusion

We introduce the first family of parton showers that achieve next-to-leading logarithmic (NLL) accuracy for processes involving a t-channel exchange of a colour-singlet, and embed them in the PanScales framework. These showers are applicable to processes such as deep inelastic scattering (DIS), vector boson fusion (VBF), and vector boson scattering (VBS). We extensively test and verify the NLL accuracy of the new showers at both fixed order and all orders across a wide range of observables. We also introduce a generalisation of the Cambridge-Aachen jet algorithm and formulate new DIS observables that exhibit a simple resummation structure. The NLL showers are compared to a standard transverse-momentum ordered dipole shower, serving as a proxy for the current state-of-the-art leading-logarithmic showers available in public codes. Depending on the observable, we find discrepancies at NLL of the order of 15%. We also present some exploratory phenomenological results for Higgs production in VBF. This work enables, for the first time, to resum simultaneously global and non-global observables for the VBF process at NLL accuracy

Diatomeas potencialmente toxígenas del Cono Sur Americano

Fil: Ferrario, Martha Elba. Departamento Científico de Ficología, Facultad de Ciencias Naturales y Museo, UNLP - Paseo del Bosque s/n, 1900 La Plata, ArgentinaFil: Sar, Eugenia Alicia. Departamento Científico de Ficología, facultad de Ciencias Naturales y Museo, UNLP- Paseo del Bosque s/n, 1900 La Plata, ArgentinaFil: Sala, Silvia Estela. Departamento Científico de Ficología, facultad de Ciencias Naturales y Museo, UNLP- Paseo del Bosque s/n, 1900 La Plata, Argentin

Pidotimod: The state of art

Despite the use of antibiotics and vaccines, the frequency of respiratory tract infections is still high and these infections interest a wide range of patients, from children to aged people, including in particular these extreme categories because of the deficiency of their immune system, due to immaturity in the former case and to "immunosenescence" in the latter. For that reason immunostimulant drugs are getting more important to prevent and to attenuate infections. Pidotimod (3-L-pyroglutamyl-L-thiazolidine-4carboxylic acid) is a synthetic dipeptide with immunomodulatory properties. We reviewed studies conducted on different categories of patients, with particular attention on children and senile patients suffering from recurrent respiratory tract infections, associated, or not, with asthma or COPD. The outcomes considered are both clinical and laboratory parameters. The common end-point of these studies is that Pidotimod has an immunomodulatory activity which is able both to improve the clinical conditions of patients and to enhance and stimulate their immunity cells (lymphocytes but not only) functions acting on adaptive and innate immunity. Pidotimod is also able to increase the concentration of salivary IgA directed against bacteria; furthermore, it can modulate airway epithelial cells functions up-regulating the expression of toll-like receptors and acting on adhesion molecules. According to studies conducted on patients with atopic asthma, it seems that Pidotimod could affect T-lymphocytes balance with a possible addictional anti-allergic activity. Furthermore, it has been demonstrated an improvement of FEV1 and PEF in asthmatic patients treated with Pidotimod. Main clinical outcomes are the reduction of the number of infectious episodes, lesser severity of signs and symptoms and, consequently, a reduction in use of antibiotics and symptomatic drugs, less working and school days lost, less mortality and morbidity. The studies considered give positive results, confirming Pidotimod's efficacy. Furthermore, many studies show a good safety profile of the drug, without recording serious adverse events and mutagenic potential, and a very low incidence of side effects. Pidotimod is also a more safe solution in patients subjected to vaccination, if compared to lyophilized polibacterial, which can't be administered for thirty days before vaccination